Onconova Therapeutics Inc (ONTX): Yeah. Their investor relations people su...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Onconova Therapeutics Inc (ONTX)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	9
Posts	183
Boards Moderated	0
Alias Born	02/03/2019

Re: None

Friday, 09/18/2020 7:35:03 AM

Friday, September 18, 2020 7:35:03 AM

Yeah. Their investor relations people suck.

-Yahoo finance analysis is projected YOY sales is plus 3,000% This Qtr. Next qtr is plus 7% projected. 2nd qtr 21 is 201% projected.

-No wonder why they say its a hold.

-R&D in this field is expensive as all get out. Their negative earnings is easily explainable with actual results and meeting competitor standards...

-Rigosertib didnt excell in PH3 but met competitor standards of survival for MDS. There hasn't been another drug in that area for 15years... They JUST BECAME A COMPETITOR.

-Rigosertib combined with their ON12330 actually reduces tumor size in colon and breast cancer.

-Rigosertib got thrown at one of the most complex cancers with multiple mutations and met standards but didnt excell. Thats a success!

-Buying more when funds become available and holding. Trader strategy just got changed on this one. Im long.

Watch their conference call where he explains all of the companies presentation for Sept 4th PDF on their site. Check out yahoo finance analysis page.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ONTX News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:38:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:36:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/08/2024 09:09:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 08:41:11 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 08:35:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 09:00:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:15:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:53:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:52:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:49:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:47:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:45:06 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:43:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:41:42 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:28:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 09:18:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 08:45:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 08:42:50 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/21/2023 08:50:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:45:14 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/12/2023 04:15:10 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/30/2023 08:46:16 PM

More ONTX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow